Drug Shortage Report for JAMP-RIZATRIPTAN ODT

Last updated on 2021-04-07 History
Report ID 137045
Drug Identification Number 02465086
Brand name JAMP-RIZATRIPTAN ODT
Common or Proper name Rizatriptan Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-10-01
Estimated end date 2021-04-30
Actual end date
Shortage status Actual shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-04-07 French Compare
v1 2021-04-07 English Compare